Substance P-like immunoreactivity in human cerebrospinal fluid

¹Charles B. Stout Neuroscience Mass Spectrometry Laboratory, College of Medicine, University of Tennessee, Memphis.

International Journal of Peptide and Protein Research

|June 1, 1989

Summary

Substance P-like immunoreactivity (SP-LI) in cerebrospinal fluid (CSF) varied significantly in non-responders to pain medication. SP-LI metabolism and precursor processing differ between patients and over short time intervals.

Area of Science:

Neuroscience
Biochemistry
Pain Research

Background:

Lower back pain is a prevalent condition with complex molecular mechanisms.
Substance P (SP) is a neuropeptide implicated in pain signaling.
Understanding SP metabolism in cerebrospinal fluid (CSF) is crucial for pain research.

Purpose of the Study:

To investigate the role of Substance P-like immunoreactivity (SP-LI) in lower back pain.
To analyze SP-LI levels and molecular species in CSF before and after lidocaine treatment.
To explore differences in SP metabolism and precursor processing in patients with lower back pain.

Main Methods:

Measurement of SP-LI in lumbar CSF from 75 lower back pain patients.
Collection of CSF samples before and after lidocaine treatment.
Analysis of SP-LI molecular species using reversed-phase High-Performance Liquid Chromatography (RP-HPLC) and Radioimmunoassay (RIA).

Main Results:

A significant difference in total SP-LI was observed between initial and post-treatment samples in pharmacological non-responders.
Qualitative and quantitative variations in SP-LI molecular species were detected within and between patient CSF samples.
HPLC-RIA analysis revealed distinct SP metabolism and precursor-processing profiles in CSF.

Conclusions:

SP-LI levels and molecular forms in CSF show dynamic changes in lower back pain patients.
Individual differences in SP metabolism and processing exist, even over short time frames.
These findings contribute to understanding the neurochemical basis of pain and potential therapeutic targets.

Related Experiment Videos

Substance P-like immunoreactivity in human cerebrospinal fluid

Related Concept Videos

Minimising Risks of Reduced Genetic Diversity in Marine Restoration.

Short report on a 6-week at-home exergaming intervention to improve balance in children with developmental coordination disorder.

Reducing Grip Uncertainty During Initial Prosthetic Hand Use Improves Eye-Hand Coordination and Lowers Mental Workload.

The corticomuscular response to experimental pain via blood flow occlusion when applied to the ipsilateral and contralateral leg during an isometric force task.

Minimally invasive laparo-thoracoscopic Ivor-Lewis esophagectomy with semi-mechanical triangular anastomosis: Short-term outcomes of 114 consecutive patients.

Short report presenting preliminary evidence of impaired corticomuscular coherence in an individual with Developmental Coordination Disorder.

Structure-activity relationship of the ring portion in backbone-cyclic C-terminal hexapeptide analogs of substance P. NMR and molecular dynamics.

Conformation of a water-soluble beta-sheet model peptide. A circular dichroism and Fourier-transform infrared spectroscopic study of double D-amino acid replacements.

Application of the allyloxycarbonyl protecting group for the indole of Trp in solid-phase peptide synthesis.

NMR solution structure of the receptor binding domain of Pseudomonas aeruginosa pilin strain P1. Identification of a beta-turn.

Kinetics of inhibition of aminoacylase activity by dithiothreitol or 2-mercaptoethanol.

Alanine scan and N-methyl amide derivatives of Ac-bombesin[7-14]. Development of a proposed binding conformation at the neuromedin B (NMB) and gastrin releasing peptide (GRP) receptors.

Related Experiment Videos

Substance P-like immunoreactivity in human cerebrospinal fluid

Area of Science:

Background:

Purpose of the Study:

Main Methods:

Main Results:

Conclusions:

Related Concept Videos

Related Articles